PBA
ALPN
Paradigm Biocapital Advisors’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,121,163
| Closed | -$84.1M | – | 44 |
|
|
2024
Q1 | $84.1M | Sell |
2,121,163
-1,055,580
| -33% | -$41.8M | 2.96% | 17 |
|
|
2023
Q4 | $60.5M | Buy |
3,176,743
+755,000
| +31% | +$14.4M | 2.83% | 16 |
|
|
2023
Q3 | $27.7M | Sell |
2,421,743
-2,218
| -0.1% | -$25.4K | 1.88% | 21 |
|
|
2023
Q2 | $24.9M | Buy |
2,423,961
+106,327
| +5% | +$1.09M | 1.93% | 19 |
|
|
2023
Q1 | $17.9M | Hold |
2,317,634
| – | – | 1.7% | 22 |
|
|
2022
Q4 | $17M | Buy |
2,317,634
+102,912
| +5% | +$756K | 2% | 19 |
|
|
2022
Q3 | $15.9M | Buy |
2,214,722
+1,387,943
| +168% | +$9.99M | 2.13% | 16 |
|
|
2022
Q2 | $7.04M | Buy |
826,779
+490,550
| +146% | +$4.17M | 1.4% | 17 |
|
|
2022
Q1 | $3.02M | Buy |
+336,229
| New | +$3.02M | 0.8% | 24 |
|